September 30, 2025
Law360 Healthcare Authority looks at the week in generics litigation.
September 29, 2025
Pfizer has asked a Delaware federal court to block generic-drug maker Prinston Pharmaceutical from moving forward with plans to sell a generic version of the arthritis drug Xeljanz that would allegedly infringe Pfizer's patent.